Research shows GLP-1 receptor agonists do not directly impair thyroid hormone production, yet weight loss itself can shift levothyroxine requirements, necessitating TSH checks every 6-8 weeks during dose adjustments
It was found that liraglutide 3.0 mg daily caused a mean weight loss of around 8% at week 52 of the trial, while semaglutide 0.2 mg, 0.3 mg, and 0.4 mg caused an average weight reduction of between 11 to 14%
4
Conversely, insufficient sleep can lead to increased appetite, impaired insulin sensitivity, and preferential loss of lean mass over fat during dieting
The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent
Understanding how to properly take berberine supplements can make the difference between experiencing its full potential and missing out on its beneficial effects